nodes	percent_of_prediction	percent_of_DWPC	metapath
Zalcitabine—Cytarabine—hematologic cancer	0.158	0.5	CrCtD
Zalcitabine—Gemcitabine—hematologic cancer	0.158	0.5	CrCtD
Zalcitabine—DCK—hematologic cancer	0.148	1	CbGaD
Zalcitabine—Lamivudine—Gemcitabine—hematologic cancer	0.0263	0.128	CrCrCtD
Zalcitabine—Gemcitabine—Cytarabine—hematologic cancer	0.0263	0.128	CrCrCtD
Zalcitabine—Lamivudine—Cytarabine—hematologic cancer	0.0263	0.128	CrCrCtD
Zalcitabine—DCK—Nelarabine—hematologic cancer	0.0251	0.105	CbGbCtD
Zalcitabine—DCK—Clofarabine—hematologic cancer	0.0229	0.0962	CbGbCtD
Zalcitabine—SLC29A2—Mercaptopurine—hematologic cancer	0.0196	0.082	CbGbCtD
Zalcitabine—SLC29A1—Fludarabine—hematologic cancer	0.0187	0.0787	CbGbCtD
Zalcitabine—DCK—Fludarabine—hematologic cancer	0.0174	0.0729	CbGbCtD
Zalcitabine—Decitabine—Pentostatin—hematologic cancer	0.016	0.078	CrCrCtD
Zalcitabine—Cytarabine—Clofarabine—hematologic cancer	0.0158	0.0769	CrCrCtD
Zalcitabine—Cytarabine—Nelarabine—hematologic cancer	0.0148	0.0723	CrCrCtD
Zalcitabine—Decitabine—Clofarabine—hematologic cancer	0.0143	0.0695	CrCrCtD
Zalcitabine—SLC29A2—Gemcitabine—hematologic cancer	0.0136	0.0569	CbGbCtD
Zalcitabine—Decitabine—Nelarabine—hematologic cancer	0.0134	0.0654	CrCrCtD
Zalcitabine—SLC29A1—Cytarabine—hematologic cancer	0.0128	0.0537	CbGbCtD
Zalcitabine—DCK—Cytarabine—hematologic cancer	0.0119	0.0497	CbGbCtD
Zalcitabine—Cytarabine—Fludarabine—hematologic cancer	0.0116	0.0564	CrCrCtD
Zalcitabine—SLC29A1—Mercaptopurine—hematologic cancer	0.0112	0.0471	CbGbCtD
Zalcitabine—DCK—Cladribine—hematologic cancer	0.0112	0.047	CbGbCtD
Zalcitabine—Cytarabine—Gemcitabine—hematologic cancer	0.0109	0.0533	CrCrCtD
Zalcitabine—Decitabine—Gemcitabine—hematologic cancer	0.00989	0.0482	CrCrCtD
Zalcitabine—Decitabine—Cytarabine—hematologic cancer	0.00989	0.0482	CrCrCtD
Zalcitabine—Decitabine—Cladribine—hematologic cancer	0.00964	0.047	CrCrCtD
Zalcitabine—SLC29A1—Gemcitabine—hematologic cancer	0.00778	0.0327	CbGbCtD
Zalcitabine—DCK—Gemcitabine—hematologic cancer	0.00721	0.0303	CbGbCtD
Zalcitabine—CYP3A43—Dexamethasone—hematologic cancer	0.00457	0.0192	CbGbCtD
Zalcitabine—CYP2C9—Bexarotene—hematologic cancer	0.00181	0.00761	CbGbCtD
Zalcitabine—CYP3A7—Ifosfamide—hematologic cancer	0.0017	0.00711	CbGbCtD
Zalcitabine—CYP3A7-CYP3A51P—Ifosfamide—hematologic cancer	0.0017	0.00711	CbGbCtD
Zalcitabine—CYP3A7-CYP3A51P—Imatinib—hematologic cancer	0.00162	0.00679	CbGbCtD
Zalcitabine—CYP3A7—Imatinib—hematologic cancer	0.00162	0.00679	CbGbCtD
Zalcitabine—CYP3A5—Daunorubicin—hematologic cancer	0.00159	0.00665	CbGbCtD
Zalcitabine—CYP2D6—Lomustine—hematologic cancer	0.00154	0.00647	CbGbCtD
Zalcitabine—CYP2C9—Idarubicin—hematologic cancer	0.0015	0.00631	CbGbCtD
Zalcitabine—CYP3A5—Thalidomide—hematologic cancer	0.00144	0.00606	CbGbCtD
Zalcitabine—SLC22A7—Methotrexate—hematologic cancer	0.00138	0.00579	CbGbCtD
Zalcitabine—CYP3A5—Teniposide—hematologic cancer	0.00138	0.00578	CbGbCtD
Zalcitabine—CYP2D6—Idarubicin—hematologic cancer	0.00137	0.00577	CbGbCtD
Zalcitabine—CYP3A5—Ifosfamide—hematologic cancer	0.00127	0.00534	CbGbCtD
Zalcitabine—CYP3A5—Imatinib—hematologic cancer	0.00121	0.0051	CbGbCtD
Zalcitabine—CYP2D6—Hydroxyurea—hematologic cancer	0.00117	0.0049	CbGbCtD
Zalcitabine—CYP2C9—Bortezomib—hematologic cancer	0.00111	0.00467	CbGbCtD
Zalcitabine—CYP3A4—Bexarotene—hematologic cancer	0.00105	0.00443	CbGbCtD
Zalcitabine—CYP2D6—Bortezomib—hematologic cancer	0.00102	0.00427	CbGbCtD
Zalcitabine—CYP3A7-CYP3A51P—Irinotecan—hematologic cancer	0.00101	0.00424	CbGbCtD
Zalcitabine—CYP3A7—Irinotecan—hematologic cancer	0.00101	0.00424	CbGbCtD
Zalcitabine—CYP3A4—Lomustine—hematologic cancer	0.000981	0.00411	CbGbCtD
Zalcitabine—CYP3A4—Busulfan—hematologic cancer	0.000981	0.00411	CbGbCtD
Zalcitabine—CYP3A5—Dasatinib—hematologic cancer	0.000976	0.00409	CbGbCtD
Zalcitabine—CYP2C9—Thalidomide—hematologic cancer	0.000969	0.00406	CbGbCtD
Zalcitabine—CYP2C9—Teniposide—hematologic cancer	0.000924	0.00388	CbGbCtD
Zalcitabine—CYP3A7-CYP3A51P—Vincristine—hematologic cancer	0.000884	0.00371	CbGbCtD
Zalcitabine—CYP3A7—Vincristine—hematologic cancer	0.000884	0.00371	CbGbCtD
Zalcitabine—CYP3A4—Thiotepa—hematologic cancer	0.000874	0.00367	CbGbCtD
Zalcitabine—CYP2C9—Ifosfamide—hematologic cancer	0.000853	0.00358	CbGbCtD
Zalcitabine—CYP2C9—Imatinib—hematologic cancer	0.000815	0.00342	CbGbCtD
Zalcitabine—CYP3A5—Irinotecan—hematologic cancer	0.000759	0.00318	CbGbCtD
Zalcitabine—CYP2D6—Imatinib—hematologic cancer	0.000745	0.00313	CbGbCtD
Zalcitabine—CYP2C9—Nilotinib—hematologic cancer	0.00074	0.00311	CbGbCtD
Zalcitabine—CYP3A4—Methoxsalen—hematologic cancer	0.00068	0.00285	CbGbCtD
Zalcitabine—CYP2D6—Nilotinib—hematologic cancer	0.000677	0.00284	CbGbCtD
Zalcitabine—CYP2D6—Vinorelbine—hematologic cancer	0.000671	0.00282	CbGbCtD
Zalcitabine—CYP3A7—Dexamethasone—hematologic cancer	0.000666	0.00279	CbGbCtD
Zalcitabine—CYP3A7-CYP3A51P—Dexamethasone—hematologic cancer	0.000666	0.00279	CbGbCtD
Zalcitabine—CYP3A5—Vincristine—hematologic cancer	0.000663	0.00278	CbGbCtD
Zalcitabine—CYP3A4—Bortezomib—hematologic cancer	0.000647	0.00271	CbGbCtD
Zalcitabine—CYP3A4—Daunorubicin—hematologic cancer	0.000618	0.00259	CbGbCtD
Zalcitabine—CYP3A5—Etoposide—hematologic cancer	0.000608	0.00255	CbGbCtD
Zalcitabine—SLC22A6—Methotrexate—hematologic cancer	0.000587	0.00246	CbGbCtD
Zalcitabine—CYP3A43—testis—hematologic cancer	0.000554	0.102	CbGeAlD
Zalcitabine—CYP3A4—Cytarabine—hematologic cancer	0.000546	0.00229	CbGbCtD
Zalcitabine—Emtricitabine—DCK—hematologic cancer	0.000541	0.276	CrCbGaD
Zalcitabine—CYP3A4—Teniposide—hematologic cancer	0.000537	0.00225	CbGbCtD
Zalcitabine—CYP3A5—Dexamethasone—hematologic cancer	0.0005	0.0021	CbGbCtD
Zalcitabine—CYP3A4—Ifosfamide—hematologic cancer	0.000496	0.00208	CbGbCtD
Zalcitabine—CYP3A4—Imatinib—hematologic cancer	0.000474	0.00199	CbGbCtD
Zalcitabine—CYP3A4—Ruxolitinib—hematologic cancer	0.000446	0.00187	CbGbCtD
Zalcitabine—SLC29A2—blood—hematologic cancer	0.000431	0.0792	CbGeAlD
Zalcitabine—CYP3A4—Nilotinib—hematologic cancer	0.00043	0.00181	CbGbCtD
Zalcitabine—CYP3A4—Vinorelbine—hematologic cancer	0.000427	0.00179	CbGbCtD
Zalcitabine—CYP2C9—Cisplatin—hematologic cancer	0.000415	0.00174	CbGbCtD
Zalcitabine—CYP2D6—Vinblastine—hematologic cancer	0.000414	0.00174	CbGbCtD
Zalcitabine—CYP3A4—Triamcinolone—hematologic cancer	0.00039	0.00164	CbGbCtD
Zalcitabine—CYP3A4—Dasatinib—hematologic cancer	0.00038	0.0016	CbGbCtD
Zalcitabine—CYP3A4—Mitoxantrone—hematologic cancer	0.000376	0.00158	CbGbCtD
Zalcitabine—CYP2C9—Dexamethasone—hematologic cancer	0.000335	0.00141	CbGbCtD
Zalcitabine—CYP3A4—Betamethasone—hematologic cancer	0.000335	0.00141	CbGbCtD
Zalcitabine—CYP3A4—Prednisolone—hematologic cancer	0.000331	0.00139	CbGbCtD
Zalcitabine—SLC29A1—hematopoietic system—hematologic cancer	0.000323	0.0592	CbGeAlD
Zalcitabine—CYP3A4—Prednisone—hematologic cancer	0.000312	0.00131	CbGbCtD
Zalcitabine—DCK—hematopoietic system—hematologic cancer	0.000308	0.0566	CbGeAlD
Zalcitabine—CYP2D6—Dexamethasone—hematologic cancer	0.000306	0.00129	CbGbCtD
Zalcitabine—CYP3A4—Irinotecan—hematologic cancer	0.000296	0.00124	CbGbCtD
Zalcitabine—CYP3A4—Vinblastine—hematologic cancer	0.000263	0.0011	CbGbCtD
Zalcitabine—CYP3A4—Vincristine—hematologic cancer	0.000259	0.00109	CbGbCtD
Zalcitabine—SLC29A2—lymph node—hematologic cancer	0.000259	0.0475	CbGeAlD
Zalcitabine—CYP2D6—Doxorubicin—hematologic cancer	0.000254	0.00107	CbGbCtD
Zalcitabine—Decitabine—DNMT3A—hematologic cancer	0.000249	0.127	CrCbGaD
Zalcitabine—SLC29A1—gonad—hematologic cancer	0.000245	0.045	CbGeAlD
Zalcitabine—CYP3A4—Etoposide—hematologic cancer	0.000237	0.000994	CbGbCtD
Zalcitabine—DCK—gonad—hematologic cancer	0.000234	0.043	CbGeAlD
Zalcitabine—SLC22A7—testis—hematologic cancer	0.000229	0.0421	CbGeAlD
Zalcitabine—SLC29A1—blood—hematologic cancer	0.000214	0.0392	CbGeAlD
Zalcitabine—SLC29A1—bone marrow—hematologic cancer	0.000207	0.038	CbGeAlD
Zalcitabine—DCK—blood—hematologic cancer	0.000204	0.0375	CbGeAlD
Zalcitabine—DCK—bone marrow—hematologic cancer	0.000198	0.0363	CbGeAlD
Zalcitabine—Decitabine—DCK—hematologic cancer	0.000195	0.0997	CrCbGaD
Zalcitabine—CYP3A4—Dexamethasone—hematologic cancer	0.000195	0.000818	CbGbCtD
Zalcitabine—Gemcitabine—CDA—hematologic cancer	0.00019	0.097	CrCbGaD
Zalcitabine—SLC29A1—lung—hematologic cancer	0.000187	0.0344	CbGeAlD
Zalcitabine—DCK—lung—hematologic cancer	0.000179	0.0329	CbGeAlD
Zalcitabine—SLC29A1—testis—hematologic cancer	0.000177	0.0325	CbGeAlD
Zalcitabine—DCK—testis—hematologic cancer	0.000169	0.031	CbGeAlD
Zalcitabine—Gemcitabine—DCK—hematologic cancer	0.000167	0.0854	CrCbGaD
Zalcitabine—DCK—Topotecan—Irinotecan—hematologic cancer	0.000164	0.186	CbGdCrCtD
Zalcitabine—CYP3A4—Doxorubicin—hematologic cancer	0.000162	0.000678	CbGbCtD
Zalcitabine—CYP3A5—hematopoietic system—hematologic cancer	0.00016	0.0293	CbGeAlD
Zalcitabine—CYP2C9—hematopoietic system—hematologic cancer	0.000157	0.0288	CbGeAlD
Zalcitabine—Lamivudine—DCK—hematologic cancer	0.000152	0.0777	CrCbGaD
Zalcitabine—Cytarabine—CDA—hematologic cancer	0.00013	0.0662	CrCbGaD
Zalcitabine—SLC29A1—lymph node—hematologic cancer	0.000128	0.0235	CbGeAlD
Zalcitabine—DCK—lymph node—hematologic cancer	0.000122	0.0225	CbGeAlD
Zalcitabine—CYP3A4—hematopoietic system—hematologic cancer	0.00012	0.022	CbGeAlD
Zalcitabine—CYP2D6—hematopoietic system—hematologic cancer	0.000118	0.0216	CbGeAlD
Zalcitabine—Cytarabine—DCK—hematologic cancer	0.000114	0.0583	CrCbGaD
Zalcitabine—DCK—Doxorubicin—Daunorubicin—hematologic cancer	0.00011	0.125	CbGdCrCtD
Zalcitabine—DCK—Epirubicin—Daunorubicin—hematologic cancer	0.00011	0.125	CbGdCrCtD
Zalcitabine—CYP3A5—blood—hematologic cancer	0.000106	0.0194	CbGeAlD
Zalcitabine—CYP2C9—blood—hematologic cancer	0.000104	0.0191	CbGeAlD
Zalcitabine—DCK—Menadione—Thalidomide—hematologic cancer	9.39e-05	0.107	CbGdCrCtD
Zalcitabine—CYP3A5—lung—hematologic cancer	9.27e-05	0.017	CbGeAlD
Zalcitabine—DCK—Epirubicin—Idarubicin—hematologic cancer	8.37e-05	0.0951	CbGdCrCtD
Zalcitabine—DCK—Doxorubicin—Idarubicin—hematologic cancer	8.37e-05	0.0951	CbGdCrCtD
Zalcitabine—CYP3A4—blood—hematologic cancer	7.94e-05	0.0146	CbGeAlD
Zalcitabine—CYP2D6—blood—hematologic cancer	7.81e-05	0.0143	CbGeAlD
Zalcitabine—Lamivudine—ABCC3—hematologic cancer	7.06e-05	0.0361	CrCbGaD
Zalcitabine—CYP2D6—testis—hematologic cancer	6.46e-05	0.0119	CbGeAlD
Zalcitabine—Lamivudine—SLC22A1—hematologic cancer	4.91e-05	0.0251	CrCbGaD
Zalcitabine—DCK—Doxorubicin—Epirubicin—hematologic cancer	3.84e-05	0.0436	CbGdCrCtD
Zalcitabine—Cytarabine—SLC22A1—hematologic cancer	3.68e-05	0.0188	CrCbGaD
Zalcitabine—DCK—Epirubicin—Doxorubicin—hematologic cancer	3.56e-05	0.0404	CbGdCrCtD
Zalcitabine—Lamivudine—ABCG2—hematologic cancer	3.43e-05	0.0175	CrCbGaD
Zalcitabine—DCK—Desoximetasone—Dexamethasone—hematologic cancer	1.7e-05	0.0193	CbGdCrCtD
Zalcitabine—DCK—Desoximetasone—Betamethasone—hematologic cancer	1.7e-05	0.0193	CbGdCrCtD
Zalcitabine—DCK—Desoximetasone—Triamcinolone—hematologic cancer	1.66e-05	0.0188	CbGdCrCtD
Zalcitabine—DCK—Diflorasone—Betamethasone—hematologic cancer	1.65e-05	0.0187	CbGdCrCtD
Zalcitabine—DCK—Diflorasone—Dexamethasone—hematologic cancer	1.65e-05	0.0187	CbGdCrCtD
Zalcitabine—DCK—Diflorasone—Triamcinolone—hematologic cancer	1.61e-05	0.0183	CbGdCrCtD
Zalcitabine—DCK—Desoximetasone—Prednisone—hematologic cancer	1.57e-05	0.0179	CbGdCrCtD
Zalcitabine—Gemcitabine—ABCB1—hematologic cancer	1.57e-05	0.00801	CrCbGaD
Zalcitabine—DCK—Desoximetasone—Prednisolone—hematologic cancer	1.54e-05	0.0174	CbGdCrCtD
Zalcitabine—DCK—Diflorasone—Prednisone—hematologic cancer	1.53e-05	0.0173	CbGdCrCtD
Zalcitabine—DCK—Diflorasone—Prednisolone—hematologic cancer	1.49e-05	0.0169	CbGdCrCtD
Zalcitabine—Lamivudine—ABCB1—hematologic cancer	1.43e-05	0.00729	CrCbGaD
Zalcitabine—Rhinitis—Doxorubicin—hematologic cancer	4.53e-06	6.35e-05	CcSEcCtD
Zalcitabine—Hepatitis—Doxorubicin—hematologic cancer	4.52e-06	6.33e-05	CcSEcCtD
Zalcitabine—Hypersensitivity—Prednisolone—hematologic cancer	4.5e-06	6.3e-05	CcSEcCtD
Zalcitabine—Pharyngitis—Doxorubicin—hematologic cancer	4.48e-06	6.28e-05	CcSEcCtD
Zalcitabine—Dyspepsia—Dexamethasone—hematologic cancer	4.48e-06	6.28e-05	CcSEcCtD
Zalcitabine—Dyspepsia—Betamethasone—hematologic cancer	4.48e-06	6.28e-05	CcSEcCtD
Zalcitabine—Urticaria—Triamcinolone—hematologic cancer	4.46e-06	6.25e-05	CcSEcCtD
Zalcitabine—Dysgeusia—Methotrexate—hematologic cancer	4.45e-06	6.23e-05	CcSEcCtD
Zalcitabine—Asthenia—Etoposide—hematologic cancer	4.44e-06	6.22e-05	CcSEcCtD
Zalcitabine—Body temperature increased—Triamcinolone—hematologic cancer	4.44e-06	6.22e-05	CcSEcCtD
Zalcitabine—Oedema—Prednisone—hematologic cancer	4.44e-06	6.22e-05	CcSEcCtD
Zalcitabine—Decreased appetite—Dexamethasone—hematologic cancer	4.43e-06	6.21e-05	CcSEcCtD
Zalcitabine—Decreased appetite—Betamethasone—hematologic cancer	4.43e-06	6.21e-05	CcSEcCtD
Zalcitabine—Infection—Prednisone—hematologic cancer	4.41e-06	6.18e-05	CcSEcCtD
Zalcitabine—Back pain—Methotrexate—hematologic cancer	4.39e-06	6.16e-05	CcSEcCtD
Zalcitabine—Fatigue—Betamethasone—hematologic cancer	4.39e-06	6.15e-05	CcSEcCtD
Zalcitabine—Fatigue—Dexamethasone—hematologic cancer	4.39e-06	6.15e-05	CcSEcCtD
Zalcitabine—Chills—Epirubicin—hematologic cancer	4.38e-06	6.14e-05	CcSEcCtD
Zalcitabine—Pruritus—Etoposide—hematologic cancer	4.38e-06	6.14e-05	CcSEcCtD
Zalcitabine—Shock—Prednisone—hematologic cancer	4.36e-06	6.12e-05	CcSEcCtD
Zalcitabine—Arrhythmia—Epirubicin—hematologic cancer	4.36e-06	6.11e-05	CcSEcCtD
Zalcitabine—Pain—Dexamethasone—hematologic cancer	4.36e-06	6.1e-05	CcSEcCtD
Zalcitabine—Pain—Betamethasone—hematologic cancer	4.36e-06	6.1e-05	CcSEcCtD
Zalcitabine—Visual impairment—Doxorubicin—hematologic cancer	4.35e-06	6.1e-05	CcSEcCtD
Zalcitabine—Tachycardia—Prednisone—hematologic cancer	4.33e-06	6.07e-05	CcSEcCtD
Zalcitabine—Alopecia—Epirubicin—hematologic cancer	4.32e-06	6.05e-05	CcSEcCtD
Zalcitabine—Skin disorder—Prednisone—hematologic cancer	4.31e-06	6.04e-05	CcSEcCtD
Zalcitabine—Vomiting—Cisplatin—hematologic cancer	4.3e-06	6.02e-05	CcSEcCtD
Zalcitabine—Hyperhidrosis—Prednisone—hematologic cancer	4.29e-06	6.01e-05	CcSEcCtD
Zalcitabine—Vision blurred—Methotrexate—hematologic cancer	4.28e-06	6e-05	CcSEcCtD
Zalcitabine—Rash—Cisplatin—hematologic cancer	4.26e-06	5.97e-05	CcSEcCtD
Zalcitabine—Dermatitis—Cisplatin—hematologic cancer	4.26e-06	5.96e-05	CcSEcCtD
Zalcitabine—Diarrhoea—Etoposide—hematologic cancer	4.23e-06	5.93e-05	CcSEcCtD
Zalcitabine—Anorexia—Prednisone—hematologic cancer	4.23e-06	5.93e-05	CcSEcCtD
Zalcitabine—Eye disorder—Doxorubicin—hematologic cancer	4.22e-06	5.92e-05	CcSEcCtD
Zalcitabine—Ill-defined disorder—Methotrexate—hematologic cancer	4.21e-06	5.91e-05	CcSEcCtD
Zalcitabine—Tinnitus—Doxorubicin—hematologic cancer	4.21e-06	5.9e-05	CcSEcCtD
Zalcitabine—Anaemia—Methotrexate—hematologic cancer	4.2e-06	5.88e-05	CcSEcCtD
Zalcitabine—Feeling abnormal—Betamethasone—hematologic cancer	4.2e-06	5.88e-05	CcSEcCtD
Zalcitabine—Feeling abnormal—Dexamethasone—hematologic cancer	4.2e-06	5.88e-05	CcSEcCtD
Zalcitabine—Flushing—Doxorubicin—hematologic cancer	4.19e-06	5.88e-05	CcSEcCtD
Zalcitabine—Flatulence—Epirubicin—hematologic cancer	4.19e-06	5.87e-05	CcSEcCtD
Zalcitabine—Tension—Epirubicin—hematologic cancer	4.17e-06	5.85e-05	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Dexamethasone—hematologic cancer	4.17e-06	5.84e-05	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Betamethasone—hematologic cancer	4.17e-06	5.84e-05	CcSEcCtD
Zalcitabine—Dysgeusia—Epirubicin—hematologic cancer	4.16e-06	5.83e-05	CcSEcCtD
Zalcitabine—Hypersensitivity—Triamcinolone—hematologic cancer	4.14e-06	5.8e-05	CcSEcCtD
Zalcitabine—Nervousness—Epirubicin—hematologic cancer	4.13e-06	5.79e-05	CcSEcCtD
Zalcitabine—Back pain—Epirubicin—hematologic cancer	4.11e-06	5.76e-05	CcSEcCtD
Zalcitabine—Malaise—Methotrexate—hematologic cancer	4.1e-06	5.74e-05	CcSEcCtD
Zalcitabine—Dizziness—Etoposide—hematologic cancer	4.09e-06	5.74e-05	CcSEcCtD
Zalcitabine—Muscle spasms—Epirubicin—hematologic cancer	4.09e-06	5.73e-05	CcSEcCtD
Zalcitabine—Vertigo—Methotrexate—hematologic cancer	4.08e-06	5.72e-05	CcSEcCtD
Zalcitabine—Leukopenia—Methotrexate—hematologic cancer	4.07e-06	5.7e-05	CcSEcCtD
Zalcitabine—Chills—Doxorubicin—hematologic cancer	4.05e-06	5.68e-05	CcSEcCtD
Zalcitabine—Urticaria—Dexamethasone—hematologic cancer	4.05e-06	5.67e-05	CcSEcCtD
Zalcitabine—Urticaria—Betamethasone—hematologic cancer	4.05e-06	5.67e-05	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Prednisone—hematologic cancer	4.04e-06	5.66e-05	CcSEcCtD
Zalcitabine—Dizziness—Prednisolone—hematologic cancer	4.04e-06	5.66e-05	CcSEcCtD
Zalcitabine—Arrhythmia—Doxorubicin—hematologic cancer	4.04e-06	5.66e-05	CcSEcCtD
Zalcitabine—Asthenia—Triamcinolone—hematologic cancer	4.03e-06	5.64e-05	CcSEcCtD
Zalcitabine—Abdominal pain—Betamethasone—hematologic cancer	4.03e-06	5.64e-05	CcSEcCtD
Zalcitabine—Body temperature increased—Betamethasone—hematologic cancer	4.03e-06	5.64e-05	CcSEcCtD
Zalcitabine—Abdominal pain—Dexamethasone—hematologic cancer	4.03e-06	5.64e-05	CcSEcCtD
Zalcitabine—Body temperature increased—Dexamethasone—hematologic cancer	4.03e-06	5.64e-05	CcSEcCtD
Zalcitabine—Insomnia—Prednisone—hematologic cancer	4.01e-06	5.62e-05	CcSEcCtD
Zalcitabine—Vision blurred—Epirubicin—hematologic cancer	4.01e-06	5.61e-05	CcSEcCtD
Zalcitabine—Alopecia—Doxorubicin—hematologic cancer	3.99e-06	5.6e-05	CcSEcCtD
Zalcitabine—Pruritus—Triamcinolone—hematologic cancer	3.97e-06	5.57e-05	CcSEcCtD
Zalcitabine—Cough—Methotrexate—hematologic cancer	3.96e-06	5.56e-05	CcSEcCtD
Zalcitabine—Ill-defined disorder—Epirubicin—hematologic cancer	3.94e-06	5.53e-05	CcSEcCtD
Zalcitabine—Convulsion—Methotrexate—hematologic cancer	3.94e-06	5.52e-05	CcSEcCtD
Zalcitabine—Vomiting—Etoposide—hematologic cancer	3.94e-06	5.52e-05	CcSEcCtD
Zalcitabine—Anaemia—Epirubicin—hematologic cancer	3.93e-06	5.51e-05	CcSEcCtD
Zalcitabine—Agitation—Epirubicin—hematologic cancer	3.91e-06	5.47e-05	CcSEcCtD
Zalcitabine—Dyspepsia—Prednisone—hematologic cancer	3.9e-06	5.47e-05	CcSEcCtD
Zalcitabine—Rash—Etoposide—hematologic cancer	3.9e-06	5.47e-05	CcSEcCtD
Zalcitabine—Dermatitis—Etoposide—hematologic cancer	3.9e-06	5.46e-05	CcSEcCtD
Zalcitabine—Headache—Etoposide—hematologic cancer	3.88e-06	5.43e-05	CcSEcCtD
Zalcitabine—Flatulence—Doxorubicin—hematologic cancer	3.88e-06	5.43e-05	CcSEcCtD
Zalcitabine—Myalgia—Methotrexate—hematologic cancer	3.87e-06	5.42e-05	CcSEcCtD
Zalcitabine—Arthralgia—Methotrexate—hematologic cancer	3.87e-06	5.42e-05	CcSEcCtD
Zalcitabine—Tension—Doxorubicin—hematologic cancer	3.86e-06	5.41e-05	CcSEcCtD
Zalcitabine—Decreased appetite—Prednisone—hematologic cancer	3.86e-06	5.4e-05	CcSEcCtD
Zalcitabine—Dysgeusia—Doxorubicin—hematologic cancer	3.85e-06	5.4e-05	CcSEcCtD
Zalcitabine—Rash—Prednisolone—hematologic cancer	3.85e-06	5.39e-05	CcSEcCtD
Zalcitabine—Dermatitis—Prednisolone—hematologic cancer	3.85e-06	5.39e-05	CcSEcCtD
Zalcitabine—Malaise—Epirubicin—hematologic cancer	3.83e-06	5.37e-05	CcSEcCtD
Zalcitabine—Fatigue—Prednisone—hematologic cancer	3.82e-06	5.36e-05	CcSEcCtD
Zalcitabine—Headache—Prednisolone—hematologic cancer	3.82e-06	5.36e-05	CcSEcCtD
Zalcitabine—Discomfort—Methotrexate—hematologic cancer	3.82e-06	5.35e-05	CcSEcCtD
Zalcitabine—Nervousness—Doxorubicin—hematologic cancer	3.82e-06	5.35e-05	CcSEcCtD
Zalcitabine—Vertigo—Epirubicin—hematologic cancer	3.82e-06	5.35e-05	CcSEcCtD
Zalcitabine—Syncope—Epirubicin—hematologic cancer	3.81e-06	5.34e-05	CcSEcCtD
Zalcitabine—Leukopenia—Epirubicin—hematologic cancer	3.81e-06	5.33e-05	CcSEcCtD
Zalcitabine—Back pain—Doxorubicin—hematologic cancer	3.8e-06	5.33e-05	CcSEcCtD
Zalcitabine—Muscle spasms—Doxorubicin—hematologic cancer	3.78e-06	5.3e-05	CcSEcCtD
Zalcitabine—Palpitations—Epirubicin—hematologic cancer	3.76e-06	5.26e-05	CcSEcCtD
Zalcitabine—Confusional state—Methotrexate—hematologic cancer	3.74e-06	5.24e-05	CcSEcCtD
Zalcitabine—Loss of consciousness—Epirubicin—hematologic cancer	3.74e-06	5.24e-05	CcSEcCtD
Zalcitabine—Dizziness—Triamcinolone—hematologic cancer	3.71e-06	5.2e-05	CcSEcCtD
Zalcitabine—Cough—Epirubicin—hematologic cancer	3.71e-06	5.2e-05	CcSEcCtD
Zalcitabine—Vision blurred—Doxorubicin—hematologic cancer	3.71e-06	5.2e-05	CcSEcCtD
Zalcitabine—Convulsion—Epirubicin—hematologic cancer	3.68e-06	5.16e-05	CcSEcCtD
Zalcitabine—Infection—Methotrexate—hematologic cancer	3.68e-06	5.16e-05	CcSEcCtD
Zalcitabine—Hypertension—Epirubicin—hematologic cancer	3.67e-06	5.14e-05	CcSEcCtD
Zalcitabine—Feeling abnormal—Prednisone—hematologic cancer	3.66e-06	5.12e-05	CcSEcCtD
Zalcitabine—Asthenia—Betamethasone—hematologic cancer	3.65e-06	5.12e-05	CcSEcCtD
Zalcitabine—Asthenia—Dexamethasone—hematologic cancer	3.65e-06	5.12e-05	CcSEcCtD
Zalcitabine—Ill-defined disorder—Doxorubicin—hematologic cancer	3.65e-06	5.11e-05	CcSEcCtD
Zalcitabine—Anaemia—Doxorubicin—hematologic cancer	3.64e-06	5.1e-05	CcSEcCtD
Zalcitabine—Thrombocytopenia—Methotrexate—hematologic cancer	3.63e-06	5.09e-05	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Prednisone—hematologic cancer	3.63e-06	5.08e-05	CcSEcCtD
Zalcitabine—Arthralgia—Epirubicin—hematologic cancer	3.62e-06	5.07e-05	CcSEcCtD
Zalcitabine—Myalgia—Epirubicin—hematologic cancer	3.62e-06	5.07e-05	CcSEcCtD
Zalcitabine—Agitation—Doxorubicin—hematologic cancer	3.61e-06	5.07e-05	CcSEcCtD
Zalcitabine—Anxiety—Epirubicin—hematologic cancer	3.61e-06	5.05e-05	CcSEcCtD
Zalcitabine—Pruritus—Dexamethasone—hematologic cancer	3.6e-06	5.05e-05	CcSEcCtD
Zalcitabine—Pruritus—Betamethasone—hematologic cancer	3.6e-06	5.05e-05	CcSEcCtD
Zalcitabine—Skin disorder—Methotrexate—hematologic cancer	3.6e-06	5.05e-05	CcSEcCtD
Zalcitabine—Hyperhidrosis—Methotrexate—hematologic cancer	3.58e-06	5.02e-05	CcSEcCtD
Zalcitabine—Discomfort—Epirubicin—hematologic cancer	3.58e-06	5.01e-05	CcSEcCtD
Zalcitabine—Vomiting—Triamcinolone—hematologic cancer	3.57e-06	5e-05	CcSEcCtD
Zalcitabine—Malaise—Doxorubicin—hematologic cancer	3.55e-06	4.97e-05	CcSEcCtD
Zalcitabine—Rash—Triamcinolone—hematologic cancer	3.54e-06	4.96e-05	CcSEcCtD
Zalcitabine—Dry mouth—Epirubicin—hematologic cancer	3.54e-06	4.96e-05	CcSEcCtD
Zalcitabine—Dermatitis—Triamcinolone—hematologic cancer	3.54e-06	4.96e-05	CcSEcCtD
Zalcitabine—Vertigo—Doxorubicin—hematologic cancer	3.53e-06	4.95e-05	CcSEcCtD
Zalcitabine—Anorexia—Methotrexate—hematologic cancer	3.53e-06	4.95e-05	CcSEcCtD
Zalcitabine—Syncope—Doxorubicin—hematologic cancer	3.53e-06	4.94e-05	CcSEcCtD
Zalcitabine—Urticaria—Prednisone—hematologic cancer	3.52e-06	4.94e-05	CcSEcCtD
Zalcitabine—Leukopenia—Doxorubicin—hematologic cancer	3.52e-06	4.93e-05	CcSEcCtD
Zalcitabine—Headache—Triamcinolone—hematologic cancer	3.52e-06	4.93e-05	CcSEcCtD
Zalcitabine—Abdominal pain—Prednisone—hematologic cancer	3.51e-06	4.91e-05	CcSEcCtD
Zalcitabine—Body temperature increased—Prednisone—hematologic cancer	3.51e-06	4.91e-05	CcSEcCtD
Zalcitabine—Confusional state—Epirubicin—hematologic cancer	3.5e-06	4.9e-05	CcSEcCtD
Zalcitabine—Diarrhoea—Dexamethasone—hematologic cancer	3.49e-06	4.88e-05	CcSEcCtD
Zalcitabine—Diarrhoea—Betamethasone—hematologic cancer	3.49e-06	4.88e-05	CcSEcCtD
Zalcitabine—Palpitations—Doxorubicin—hematologic cancer	3.48e-06	4.87e-05	CcSEcCtD
Zalcitabine—Oedema—Epirubicin—hematologic cancer	3.47e-06	4.86e-05	CcSEcCtD
Zalcitabine—Loss of consciousness—Doxorubicin—hematologic cancer	3.46e-06	4.85e-05	CcSEcCtD
Zalcitabine—Infection—Epirubicin—hematologic cancer	3.45e-06	4.83e-05	CcSEcCtD
Zalcitabine—Cough—Doxorubicin—hematologic cancer	3.43e-06	4.81e-05	CcSEcCtD
Zalcitabine—Shock—Epirubicin—hematologic cancer	3.41e-06	4.78e-05	CcSEcCtD
Zalcitabine—Convulsion—Doxorubicin—hematologic cancer	3.41e-06	4.78e-05	CcSEcCtD
Zalcitabine—Thrombocytopenia—Epirubicin—hematologic cancer	3.4e-06	4.76e-05	CcSEcCtD
Zalcitabine—Hypertension—Doxorubicin—hematologic cancer	3.4e-06	4.76e-05	CcSEcCtD
Zalcitabine—Tachycardia—Epirubicin—hematologic cancer	3.39e-06	4.75e-05	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Methotrexate—hematologic cancer	3.38e-06	4.73e-05	CcSEcCtD
Zalcitabine—Skin disorder—Epirubicin—hematologic cancer	3.37e-06	4.72e-05	CcSEcCtD
Zalcitabine—Dizziness—Dexamethasone—hematologic cancer	3.37e-06	4.72e-05	CcSEcCtD
Zalcitabine—Dizziness—Betamethasone—hematologic cancer	3.37e-06	4.72e-05	CcSEcCtD
Zalcitabine—Hyperhidrosis—Epirubicin—hematologic cancer	3.35e-06	4.7e-05	CcSEcCtD
Zalcitabine—Insomnia—Methotrexate—hematologic cancer	3.35e-06	4.7e-05	CcSEcCtD
Zalcitabine—Arthralgia—Doxorubicin—hematologic cancer	3.35e-06	4.69e-05	CcSEcCtD
Zalcitabine—Myalgia—Doxorubicin—hematologic cancer	3.35e-06	4.69e-05	CcSEcCtD
Zalcitabine—Anxiety—Doxorubicin—hematologic cancer	3.34e-06	4.68e-05	CcSEcCtD
Zalcitabine—Discomfort—Doxorubicin—hematologic cancer	3.31e-06	4.64e-05	CcSEcCtD
Zalcitabine—Anorexia—Epirubicin—hematologic cancer	3.31e-06	4.63e-05	CcSEcCtD
Zalcitabine—Dyspnoea—Methotrexate—hematologic cancer	3.31e-06	4.63e-05	CcSEcCtD
Zalcitabine—Somnolence—Methotrexate—hematologic cancer	3.3e-06	4.62e-05	CcSEcCtD
Zalcitabine—Dry mouth—Doxorubicin—hematologic cancer	3.27e-06	4.59e-05	CcSEcCtD
Zalcitabine—Hypersensitivity—Prednisone—hematologic cancer	3.27e-06	4.58e-05	CcSEcCtD
Zalcitabine—Dyspepsia—Methotrexate—hematologic cancer	3.26e-06	4.57e-05	CcSEcCtD
Zalcitabine—Vomiting—Dexamethasone—hematologic cancer	3.24e-06	4.54e-05	CcSEcCtD
Zalcitabine—Vomiting—Betamethasone—hematologic cancer	3.24e-06	4.54e-05	CcSEcCtD
Zalcitabine—Confusional state—Doxorubicin—hematologic cancer	3.24e-06	4.54e-05	CcSEcCtD
Zalcitabine—Decreased appetite—Methotrexate—hematologic cancer	3.22e-06	4.52e-05	CcSEcCtD
Zalcitabine—Rash—Betamethasone—hematologic cancer	3.21e-06	4.5e-05	CcSEcCtD
Zalcitabine—Rash—Dexamethasone—hematologic cancer	3.21e-06	4.5e-05	CcSEcCtD
Zalcitabine—Oedema—Doxorubicin—hematologic cancer	3.21e-06	4.5e-05	CcSEcCtD
Zalcitabine—Dermatitis—Dexamethasone—hematologic cancer	3.21e-06	4.5e-05	CcSEcCtD
Zalcitabine—Dermatitis—Betamethasone—hematologic cancer	3.21e-06	4.5e-05	CcSEcCtD
Zalcitabine—Fatigue—Methotrexate—hematologic cancer	3.2e-06	4.48e-05	CcSEcCtD
Zalcitabine—Headache—Dexamethasone—hematologic cancer	3.19e-06	4.47e-05	CcSEcCtD
Zalcitabine—Headache—Betamethasone—hematologic cancer	3.19e-06	4.47e-05	CcSEcCtD
Zalcitabine—Infection—Doxorubicin—hematologic cancer	3.19e-06	4.47e-05	CcSEcCtD
Zalcitabine—Asthenia—Prednisone—hematologic cancer	3.18e-06	4.46e-05	CcSEcCtD
Zalcitabine—Pain—Methotrexate—hematologic cancer	3.17e-06	4.44e-05	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Epirubicin—hematologic cancer	3.16e-06	4.43e-05	CcSEcCtD
Zalcitabine—Shock—Doxorubicin—hematologic cancer	3.16e-06	4.43e-05	CcSEcCtD
Zalcitabine—Thrombocytopenia—Doxorubicin—hematologic cancer	3.14e-06	4.4e-05	CcSEcCtD
Zalcitabine—Pruritus—Prednisone—hematologic cancer	3.14e-06	4.4e-05	CcSEcCtD
Zalcitabine—Insomnia—Epirubicin—hematologic cancer	3.14e-06	4.4e-05	CcSEcCtD
Zalcitabine—Tachycardia—Doxorubicin—hematologic cancer	3.13e-06	4.39e-05	CcSEcCtD
Zalcitabine—Skin disorder—Doxorubicin—hematologic cancer	3.12e-06	4.37e-05	CcSEcCtD
Zalcitabine—Hyperhidrosis—Doxorubicin—hematologic cancer	3.1e-06	4.35e-05	CcSEcCtD
Zalcitabine—Dyspnoea—Epirubicin—hematologic cancer	3.09e-06	4.33e-05	CcSEcCtD
Zalcitabine—Somnolence—Epirubicin—hematologic cancer	3.08e-06	4.32e-05	CcSEcCtD
Zalcitabine—Anorexia—Doxorubicin—hematologic cancer	3.06e-06	4.29e-05	CcSEcCtD
Zalcitabine—Feeling abnormal—Methotrexate—hematologic cancer	3.05e-06	4.28e-05	CcSEcCtD
Zalcitabine—Dyspepsia—Epirubicin—hematologic cancer	3.05e-06	4.28e-05	CcSEcCtD
Zalcitabine—Diarrhoea—Prednisone—hematologic cancer	3.04e-06	4.25e-05	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Methotrexate—hematologic cancer	3.03e-06	4.25e-05	CcSEcCtD
Zalcitabine—Decreased appetite—Epirubicin—hematologic cancer	3.02e-06	4.23e-05	CcSEcCtD
Zalcitabine—Fatigue—Epirubicin—hematologic cancer	2.99e-06	4.19e-05	CcSEcCtD
Zalcitabine—Pain—Epirubicin—hematologic cancer	2.97e-06	4.16e-05	CcSEcCtD
Zalcitabine—Urticaria—Methotrexate—hematologic cancer	2.95e-06	4.13e-05	CcSEcCtD
Zalcitabine—Dizziness—Prednisone—hematologic cancer	2.93e-06	4.11e-05	CcSEcCtD
Zalcitabine—Abdominal pain—Methotrexate—hematologic cancer	2.93e-06	4.11e-05	CcSEcCtD
Zalcitabine—Body temperature increased—Methotrexate—hematologic cancer	2.93e-06	4.11e-05	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	2.92e-06	4.1e-05	CcSEcCtD
Zalcitabine—Insomnia—Doxorubicin—hematologic cancer	2.9e-06	4.07e-05	CcSEcCtD
Zalcitabine—Dyspnoea—Doxorubicin—hematologic cancer	2.86e-06	4.01e-05	CcSEcCtD
Zalcitabine—Feeling abnormal—Epirubicin—hematologic cancer	2.86e-06	4.01e-05	CcSEcCtD
Zalcitabine—Somnolence—Doxorubicin—hematologic cancer	2.85e-06	4e-05	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Epirubicin—hematologic cancer	2.84e-06	3.98e-05	CcSEcCtD
Zalcitabine—Dyspepsia—Doxorubicin—hematologic cancer	2.83e-06	3.96e-05	CcSEcCtD
Zalcitabine—Vomiting—Prednisone—hematologic cancer	2.82e-06	3.95e-05	CcSEcCtD
Zalcitabine—Rash—Prednisone—hematologic cancer	2.8e-06	3.92e-05	CcSEcCtD
Zalcitabine—Dermatitis—Prednisone—hematologic cancer	2.79e-06	3.92e-05	CcSEcCtD
Zalcitabine—Decreased appetite—Doxorubicin—hematologic cancer	2.79e-06	3.91e-05	CcSEcCtD
Zalcitabine—Headache—Prednisone—hematologic cancer	2.78e-06	3.89e-05	CcSEcCtD
Zalcitabine—Fatigue—Doxorubicin—hematologic cancer	2.77e-06	3.88e-05	CcSEcCtD
Zalcitabine—Urticaria—Epirubicin—hematologic cancer	2.76e-06	3.86e-05	CcSEcCtD
Zalcitabine—Pain—Doxorubicin—hematologic cancer	2.75e-06	3.85e-05	CcSEcCtD
Zalcitabine—Abdominal pain—Epirubicin—hematologic cancer	2.74e-06	3.84e-05	CcSEcCtD
Zalcitabine—Body temperature increased—Epirubicin—hematologic cancer	2.74e-06	3.84e-05	CcSEcCtD
Zalcitabine—Hypersensitivity—Methotrexate—hematologic cancer	2.73e-06	3.83e-05	CcSEcCtD
Zalcitabine—Asthenia—Methotrexate—hematologic cancer	2.66e-06	3.73e-05	CcSEcCtD
Zalcitabine—Feeling abnormal—Doxorubicin—hematologic cancer	2.65e-06	3.71e-05	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Doxorubicin—hematologic cancer	2.62e-06	3.68e-05	CcSEcCtD
Zalcitabine—Pruritus—Methotrexate—hematologic cancer	2.62e-06	3.68e-05	CcSEcCtD
Zalcitabine—Hypersensitivity—Epirubicin—hematologic cancer	2.56e-06	3.58e-05	CcSEcCtD
Zalcitabine—Urticaria—Doxorubicin—hematologic cancer	2.55e-06	3.57e-05	CcSEcCtD
Zalcitabine—CYP3A7—Metabolism—NCOA3—hematologic cancer	2.55e-06	0.000206	CbGpPWpGaD
Zalcitabine—Abdominal pain—Doxorubicin—hematologic cancer	2.54e-06	3.56e-05	CcSEcCtD
Zalcitabine—Body temperature increased—Doxorubicin—hematologic cancer	2.54e-06	3.56e-05	CcSEcCtD
Zalcitabine—Diarrhoea—Methotrexate—hematologic cancer	2.54e-06	3.55e-05	CcSEcCtD
Zalcitabine—CYP3A7—Metabolism—NUP214—hematologic cancer	2.53e-06	0.000204	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—PC—hematologic cancer	2.51e-06	0.000203	CbGpPWpGaD
Zalcitabine—Asthenia—Epirubicin—hematologic cancer	2.49e-06	3.49e-05	CcSEcCtD
Zalcitabine—CYP2C9—Metabolism—PC—hematologic cancer	2.49e-06	0.000201	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—MTR—hematologic cancer	2.48e-06	0.0002	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—ABCG2—hematologic cancer	2.48e-06	0.0002	CbGpPWpGaD
Zalcitabine—SLC22A6—Transmembrane transport of small molecules—ALB—hematologic cancer	2.47e-06	0.0002	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—PIK3CD—hematologic cancer	2.47e-06	0.000199	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—FTCD—hematologic cancer	2.46e-06	0.000199	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PHYH—hematologic cancer	2.46e-06	0.000199	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—GMPS—hematologic cancer	2.46e-06	0.000199	CbGpPWpGaD
Zalcitabine—Pruritus—Epirubicin—hematologic cancer	2.45e-06	3.44e-05	CcSEcCtD
Zalcitabine—Dizziness—Methotrexate—hematologic cancer	2.45e-06	3.44e-05	CcSEcCtD
Zalcitabine—DCK—Metabolism—ALB—hematologic cancer	2.44e-06	0.000197	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—PIK3CD—hematologic cancer	2.43e-06	0.000196	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—ENO2—hematologic cancer	2.43e-06	0.000196	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—ARNTL—hematologic cancer	2.43e-06	0.000196	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—SLC35B2—hematologic cancer	2.42e-06	0.000196	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—GBA—hematologic cancer	2.42e-06	0.000196	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—SLC35B2—hematologic cancer	2.4e-06	0.000194	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—GBA—hematologic cancer	2.4e-06	0.000194	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—ALB—hematologic cancer	2.4e-06	0.000194	CbGpPWpGaD
Zalcitabine—Diarrhoea—Epirubicin—hematologic cancer	2.37e-06	3.33e-05	CcSEcCtD
Zalcitabine—Hypersensitivity—Doxorubicin—hematologic cancer	2.37e-06	3.31e-05	CcSEcCtD
Zalcitabine—CYP3A5—Metabolism—ACP5—hematologic cancer	2.36e-06	0.000191	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—CA9—hematologic cancer	2.36e-06	0.000191	CbGpPWpGaD
Zalcitabine—Vomiting—Methotrexate—hematologic cancer	2.36e-06	3.3e-05	CcSEcCtD
Zalcitabine—CYP3A7—Metabolism—GSTT1—hematologic cancer	2.36e-06	0.00019	CbGpPWpGaD
Zalcitabine—Rash—Methotrexate—hematologic cancer	2.34e-06	3.28e-05	CcSEcCtD
Zalcitabine—Dermatitis—Methotrexate—hematologic cancer	2.34e-06	3.27e-05	CcSEcCtD
Zalcitabine—DCK—Metabolism—PIK3R1—hematologic cancer	2.33e-06	0.000188	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—NCOR2—hematologic cancer	2.33e-06	0.000188	CbGpPWpGaD
Zalcitabine—Headache—Methotrexate—hematologic cancer	2.32e-06	3.25e-05	CcSEcCtD
Zalcitabine—Asthenia—Doxorubicin—hematologic cancer	2.3e-06	3.23e-05	CcSEcCtD
Zalcitabine—CYP3A7—Metabolism—SDC1—hematologic cancer	2.3e-06	0.000186	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—PIK3R1—hematologic cancer	2.3e-06	0.000185	CbGpPWpGaD
Zalcitabine—Dizziness—Epirubicin—hematologic cancer	2.29e-06	3.22e-05	CcSEcCtD
Zalcitabine—Pruritus—Doxorubicin—hematologic cancer	2.27e-06	3.18e-05	CcSEcCtD
Zalcitabine—CYP3A4—Metabolism—SMPD3—hematologic cancer	2.25e-06	0.000182	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—IDH1—hematologic cancer	2.22e-06	0.000179	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—MTAP—hematologic cancer	2.22e-06	0.000179	CbGpPWpGaD
Zalcitabine—Vomiting—Epirubicin—hematologic cancer	2.21e-06	3.09e-05	CcSEcCtD
Zalcitabine—CYP2C9—Metabolism—MTAP—hematologic cancer	2.2e-06	0.000177	CbGpPWpGaD
Zalcitabine—Diarrhoea—Doxorubicin—hematologic cancer	2.2e-06	3.08e-05	CcSEcCtD
Zalcitabine—CYP3A5—Metabolism—ABCC3—hematologic cancer	2.2e-06	0.000177	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—TXN—hematologic cancer	2.2e-06	0.000177	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—GSTO1—hematologic cancer	2.2e-06	0.000177	CbGpPWpGaD
Zalcitabine—Rash—Epirubicin—hematologic cancer	2.19e-06	3.07e-05	CcSEcCtD
Zalcitabine—Dermatitis—Epirubicin—hematologic cancer	2.19e-06	3.06e-05	CcSEcCtD
Zalcitabine—Headache—Epirubicin—hematologic cancer	2.17e-06	3.05e-05	CcSEcCtD
Zalcitabine—DCK—Metabolism—PIK3CB—hematologic cancer	2.15e-06	0.000174	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—SPHK1—hematologic cancer	2.15e-06	0.000174	CbGpPWpGaD
Zalcitabine—Dizziness—Doxorubicin—hematologic cancer	2.12e-06	2.98e-05	CcSEcCtD
Zalcitabine—CYP3A43—Metabolism—PIK3CB—hematologic cancer	2.12e-06	0.000171	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—UGT1A1—hematologic cancer	2.06e-06	0.000167	CbGpPWpGaD
Zalcitabine—Vomiting—Doxorubicin—hematologic cancer	2.04e-06	2.86e-05	CcSEcCtD
Zalcitabine—Rash—Doxorubicin—hematologic cancer	2.02e-06	2.84e-05	CcSEcCtD
Zalcitabine—Dermatitis—Doxorubicin—hematologic cancer	2.02e-06	2.83e-05	CcSEcCtD
Zalcitabine—Headache—Doxorubicin—hematologic cancer	2.01e-06	2.82e-05	CcSEcCtD
Zalcitabine—CYP3A5—Metabolism—SLC22A1—hematologic cancer	2.01e-06	0.000162	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—CRABP1—hematologic cancer	2.01e-06	0.000162	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—FHL2—hematologic cancer	1.98e-06	0.00016	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—DCK—hematologic cancer	1.97e-06	0.000159	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—ASNS—hematologic cancer	1.97e-06	0.000159	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—B3GAT1—hematologic cancer	1.97e-06	0.000159	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—FHL2—hematologic cancer	1.96e-06	0.000158	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—CD44—hematologic cancer	1.96e-06	0.000158	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—NQO1—hematologic cancer	1.96e-06	0.000158	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—ALOX5—hematologic cancer	1.96e-06	0.000158	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—AGRN—hematologic cancer	1.94e-06	0.000156	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—AGRN—hematologic cancer	1.92e-06	0.000155	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—NUP98—hematologic cancer	1.9e-06	0.000153	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—HDC—hematologic cancer	1.86e-06	0.000151	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—PTEN—hematologic cancer	1.86e-06	0.00015	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—CYCS—hematologic cancer	1.85e-06	0.00015	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—HSP90AA1—hematologic cancer	1.84e-06	0.000149	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—ADCY7—hematologic cancer	1.84e-06	0.000149	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—NCOA3—hematologic cancer	1.84e-06	0.000149	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—IDH2—hematologic cancer	1.84e-06	0.000148	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—HMMR—hematologic cancer	1.84e-06	0.000148	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—PTEN—hematologic cancer	1.83e-06	0.000148	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—NUP214—hematologic cancer	1.83e-06	0.000148	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—IDH2—hematologic cancer	1.82e-06	0.000147	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—HMMR—hematologic cancer	1.82e-06	0.000147	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—MTR—hematologic cancer	1.79e-06	0.000145	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—ABCG2—hematologic cancer	1.79e-06	0.000145	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—EP300—hematologic cancer	1.77e-06	0.000143	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—ENO2—hematologic cancer	1.76e-06	0.000142	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—EP300—hematologic cancer	1.75e-06	0.000141	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—ARNTL—hematologic cancer	1.73e-06	0.000139	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	1.72e-06	0.000139	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—ARNTL—hematologic cancer	1.71e-06	0.000138	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—CDA—hematologic cancer	1.7e-06	0.000138	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—GSTT1—hematologic cancer	1.7e-06	0.000138	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—CA9—hematologic cancer	1.68e-06	0.000136	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—ACP5—hematologic cancer	1.68e-06	0.000136	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—ACP5—hematologic cancer	1.67e-06	0.000134	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—CA9—hematologic cancer	1.67e-06	0.000134	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—SDC1—hematologic cancer	1.66e-06	0.000134	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—NCOR2—hematologic cancer	1.66e-06	0.000134	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—NCOR2—hematologic cancer	1.64e-06	0.000133	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PC—hematologic cancer	1.64e-06	0.000133	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—GSTP1—hematologic cancer	1.63e-06	0.000132	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—GBA—hematologic cancer	1.58e-06	0.000128	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—SLC35B2—hematologic cancer	1.58e-06	0.000128	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—IDH1—hematologic cancer	1.58e-06	0.000128	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—IDH1—hematologic cancer	1.57e-06	0.000126	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—TXN—hematologic cancer	1.56e-06	0.000126	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—ABCC3—hematologic cancer	1.56e-06	0.000126	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—GSTO1—hematologic cancer	1.56e-06	0.000126	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—GSTO1—hematologic cancer	1.55e-06	0.000125	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—TXN—hematologic cancer	1.55e-06	0.000125	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—ABCC3—hematologic cancer	1.55e-06	0.000125	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—ABCB1—hematologic cancer	1.55e-06	0.000125	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—SPHK1—hematologic cancer	1.53e-06	0.000123	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—SPHK1—hematologic cancer	1.51e-06	0.000122	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—GSTM1—hematologic cancer	1.5e-06	0.000121	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—NCOR1—hematologic cancer	1.5e-06	0.000121	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—UGT1A1—hematologic cancer	1.47e-06	0.000119	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—UGT1A1—hematologic cancer	1.46e-06	0.000118	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—MTAP—hematologic cancer	1.45e-06	0.000117	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—CRABP1—hematologic cancer	1.43e-06	0.000115	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—SLC22A1—hematologic cancer	1.43e-06	0.000115	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—CRABP1—hematologic cancer	1.42e-06	0.000114	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—SLC22A1—hematologic cancer	1.42e-06	0.000114	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—CD44—hematologic cancer	1.42e-06	0.000114	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—NQO1—hematologic cancer	1.42e-06	0.000114	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—ALOX5—hematologic cancer	1.39e-06	0.000112	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—ALOX5—hematologic cancer	1.38e-06	0.000111	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—NUP98—hematologic cancer	1.35e-06	0.000109	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—CYCS—hematologic cancer	1.34e-06	0.000108	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—NUP98—hematologic cancer	1.34e-06	0.000108	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—HSP90AA1—hematologic cancer	1.33e-06	0.000107	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—MTHFR—hematologic cancer	1.33e-06	0.000107	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—PIK3CA—hematologic cancer	1.31e-06	0.000106	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—ADCY7—hematologic cancer	1.31e-06	0.000106	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—NCOA3—hematologic cancer	1.31e-06	0.000106	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—NUP214—hematologic cancer	1.3e-06	0.000105	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—NCOA3—hematologic cancer	1.3e-06	0.000105	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—ADCY7—hematologic cancer	1.3e-06	0.000105	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—PIK3CA—hematologic cancer	1.29e-06	0.000104	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—FHL2—hematologic cancer	1.29e-06	0.000104	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—NUP214—hematologic cancer	1.29e-06	0.000104	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	1.27e-06	0.000103	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—ABCG2—hematologic cancer	1.27e-06	0.000103	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—MTR—hematologic cancer	1.27e-06	0.000103	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—AGRN—hematologic cancer	1.27e-06	0.000102	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—MTR—hematologic cancer	1.26e-06	0.000102	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—ABCG2—hematologic cancer	1.26e-06	0.000102	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—ENO2—hematologic cancer	1.25e-06	0.000101	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—ENO2—hematologic cancer	1.24e-06	0.0001	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—GSTT1—hematologic cancer	1.21e-06	9.78e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—IDH2—hematologic cancer	1.2e-06	9.7e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—HMMR—hematologic cancer	1.2e-06	9.7e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—GSTT1—hematologic cancer	1.2e-06	9.7e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—SDC1—hematologic cancer	1.18e-06	9.56e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	1.18e-06	9.55e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—GSTP1—hematologic cancer	1.18e-06	9.53e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—SDC1—hematologic cancer	1.17e-06	9.48e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—ARNTL—hematologic cancer	1.13e-06	9.12e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	1.12e-06	9.05e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—ABCB1—hematologic cancer	1.12e-06	9.02e-05	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—PIK3CG—hematologic cancer	1.11e-06	9e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	1.11e-06	8.94e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—CA9—hematologic cancer	1.1e-06	8.87e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—ACP5—hematologic cancer	1.1e-06	8.87e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—NCOR1—hematologic cancer	1.08e-06	8.76e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—GSTM1—hematologic cancer	1.08e-06	8.76e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—NCOR2—hematologic cancer	1.08e-06	8.75e-05	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—AKT1—hematologic cancer	1.07e-06	8.66e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	1.06e-06	8.55e-05	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—AKT1—hematologic cancer	1.06e-06	8.53e-05	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—CREBBP—hematologic cancer	1.03e-06	8.34e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—IDH1—hematologic cancer	1.03e-06	8.34e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—GSTO1—hematologic cancer	1.02e-06	8.25e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—ABCC3—hematologic cancer	1.02e-06	8.25e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—TXN—hematologic cancer	1.02e-06	8.25e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—NQO1—hematologic cancer	1.01e-06	8.13e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—CD44—hematologic cancer	1.01e-06	8.13e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—SPHK1—hematologic cancer	9.99e-07	8.07e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—NQO1—hematologic cancer	9.98e-07	8.06e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—CD44—hematologic cancer	9.98e-07	8.06e-05	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—PIK3CD—hematologic cancer	9.79e-07	7.91e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	9.77e-07	7.89e-05	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—ALB—hematologic cancer	9.67e-07	7.81e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—UGT1A1—hematologic cancer	9.6e-07	7.75e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—MTHFR—hematologic cancer	9.59e-07	7.74e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—CYCS—hematologic cancer	9.52e-07	7.69e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—HSP90AA1—hematologic cancer	9.46e-07	7.64e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—CYCS—hematologic cancer	9.44e-07	7.62e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	9.38e-07	7.58e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—SLC22A1—hematologic cancer	9.34e-07	7.54e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—CRABP1—hematologic cancer	9.34e-07	7.54e-05	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—PIK3R1—hematologic cancer	9.25e-07	7.47e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—ALOX5—hematologic cancer	9.1e-07	7.35e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—NUP98—hematologic cancer	8.81e-07	7.12e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—ADCY7—hematologic cancer	8.56e-07	6.91e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—NCOA3—hematologic cancer	8.56e-07	6.91e-05	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—PIK3CB—hematologic cancer	8.54e-07	6.9e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—NUP214—hematologic cancer	8.5e-07	6.86e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	8.44e-07	6.82e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—GSTP1—hematologic cancer	8.39e-07	6.78e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—MTR—hematologic cancer	8.32e-07	6.72e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—ABCG2—hematologic cancer	8.32e-07	6.72e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—GSTP1—hematologic cancer	8.32e-07	6.72e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—ENO2—hematologic cancer	8.16e-07	6.59e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—PIK3CG—hematologic cancer	8.05e-07	6.5e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	8.05e-07	6.5e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—ABCB1—hematologic cancer	7.94e-07	6.42e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—GSTT1—hematologic cancer	7.92e-07	6.39e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—ABCB1—hematologic cancer	7.88e-07	6.36e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—SDC1—hematologic cancer	7.74e-07	6.25e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—NCOR1—hematologic cancer	7.71e-07	6.23e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—GSTM1—hematologic cancer	7.71e-07	6.23e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—GSTM1—hematologic cancer	7.65e-07	6.18e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—NCOR1—hematologic cancer	7.65e-07	6.18e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—CREBBP—hematologic cancer	7.47e-07	6.03e-05	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—PTEN—hematologic cancer	7.38e-07	5.96e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—PIK3CD—hematologic cancer	7.08e-07	5.72e-05	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—EP300—hematologic cancer	7.04e-07	5.68e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—ALB—hematologic cancer	6.99e-07	5.65e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—MTHFR—hematologic cancer	6.82e-07	5.51e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—MTHFR—hematologic cancer	6.76e-07	5.46e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—PIK3R1—hematologic cancer	6.69e-07	5.4e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—CD44—hematologic cancer	6.58e-07	5.31e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—NQO1—hematologic cancer	6.58e-07	5.31e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—CYCS—hematologic cancer	6.23e-07	5.03e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	6.19e-07	5e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—PIK3CB—hematologic cancer	6.17e-07	4.98e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	5.95e-07	4.81e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—PIK3CG—hematologic cancer	5.73e-07	4.63e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—PIK3CG—hematologic cancer	5.68e-07	4.59e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—GSTP1—hematologic cancer	5.49e-07	4.43e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—PTEN—hematologic cancer	5.33e-07	4.31e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—CREBBP—hematologic cancer	5.31e-07	4.29e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—CREBBP—hematologic cancer	5.26e-07	4.25e-05	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—PIK3CA—hematologic cancer	5.2e-07	4.2e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—ABCB1—hematologic cancer	5.19e-07	4.2e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—EP300—hematologic cancer	5.09e-07	4.11e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—GSTM1—hematologic cancer	5.04e-07	4.07e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—NCOR1—hematologic cancer	5.04e-07	4.07e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—PIK3CD—hematologic cancer	5.03e-07	4.07e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—PIK3CD—hematologic cancer	4.99e-07	4.03e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—ALB—hematologic cancer	4.97e-07	4.01e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—ALB—hematologic cancer	4.93e-07	3.98e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—PIK3R1—hematologic cancer	4.75e-07	3.84e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—PIK3R1—hematologic cancer	4.71e-07	3.81e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—MTHFR—hematologic cancer	4.46e-07	3.6e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—PIK3CB—hematologic cancer	4.39e-07	3.54e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—PIK3CB—hematologic cancer	4.35e-07	3.51e-05	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—AKT1—hematologic cancer	4.25e-07	3.43e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—PTEN—hematologic cancer	3.79e-07	3.06e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—PIK3CA—hematologic cancer	3.76e-07	3.04e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—PTEN—hematologic cancer	3.76e-07	3.04e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PIK3CG—hematologic cancer	3.74e-07	3.02e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—EP300—hematologic cancer	3.62e-07	2.92e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—EP300—hematologic cancer	3.59e-07	2.9e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—CREBBP—hematologic cancer	3.47e-07	2.8e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PIK3CD—hematologic cancer	3.29e-07	2.66e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—ALB—hematologic cancer	3.25e-07	2.62e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PIK3R1—hematologic cancer	3.11e-07	2.51e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—AKT1—hematologic cancer	3.07e-07	2.48e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PIK3CB—hematologic cancer	2.87e-07	2.32e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—PIK3CA—hematologic cancer	2.68e-07	2.16e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—PIK3CA—hematologic cancer	2.65e-07	2.14e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PTEN—hematologic cancer	2.48e-07	2e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—EP300—hematologic cancer	2.36e-07	1.91e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—AKT1—hematologic cancer	2.19e-07	1.77e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—AKT1—hematologic cancer	2.17e-07	1.75e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PIK3CA—hematologic cancer	1.75e-07	1.41e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—AKT1—hematologic cancer	1.43e-07	1.15e-05	CbGpPWpGaD
